Table of Contents Author Guidelines Submit a Manuscript
Mediators of Inflammation
Volume 2015, Article ID 737310, 16 pages
http://dx.doi.org/10.1155/2015/737310
Research Article

Role of Calprotectin as a Modulator of the IL27-Mediated Proinflammatory Effect on Endothelial Cells

1Life Sciences Research Unit, University of Luxembourg, 162a Avenue de la Faïencerie, 1511 Luxembourg City, Luxembourg
2Institute for Experimental Internal Medicine, Otto-von-Guericke University Magdeburg, Leipziger Straße 44, 39120 Magdeburg, Germany

Received 4 September 2015; Accepted 21 October 2015

Academic Editor: Pilar Alcaide

Copyright © 2015 Susann A. Dorosz et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. Y. Sonobe, I. Yawata, J. Kawanokuchi, H. Takeuchi, T. Mizuno, and A. Suzumura, “Production of IL-27 and other IL-12 family cytokines by microglia and their subpopulations,” Brain Research, vol. 1040, no. 1-2, pp. 202–207, 2005. View at Publisher · View at Google Scholar · View at Scopus
  2. P. Rajendran, T. Rengarajan, J. Thangavel et al., “The vascular endothelium and human diseases,” International Journal of Biological Sciences, vol. 9, no. 10, pp. 1057–1069, 2013. View at Publisher · View at Google Scholar · View at Scopus
  3. M. Khazaei, F. Moien-afshari, and I. Laher, “Vascular endothelial function in health and diseases,” Pathophysiology, vol. 15, no. 1, pp. 49–67, 2008. View at Publisher · View at Google Scholar · View at Scopus
  4. J. Herrmann and A. Lerman, “The endothelium: dysfunction and beyond,” Journal of Nuclear Cardiology, vol. 8, no. 2, pp. 197–206, 2001. View at Publisher · View at Google Scholar · View at Scopus
  5. W. C. Aird, “Phenotypic heterogeneity of the endothelium: I. Structure, function, and mechanisms,” Circulation Research, vol. 100, no. 2, pp. 158–173, 2007. View at Publisher · View at Google Scholar · View at Scopus
  6. H. A. R. Hadi, C. S. Carr, and J. Al Suwaidi, “Endothelial dysfunction: cardiovascular risk factors, therapy, and outcome,” Vascular Health and Risk Management, vol. 1, no. 3, pp. 183–198, 2005. View at Google Scholar · View at Scopus
  7. G. M. Rubanyi, “The role of endothelium in cardiovascular homeostasis and diseases,” Journal of Cardiovascular Pharmacology, vol. 22, no. 4, pp. S1–S14, 1993. View at Google Scholar · View at Scopus
  8. D. B. Cines, E. S. Pollak, C. A. Buck et al., “Endothelial cells in physiology and in the pathophysiology of vascular disorders,” Blood, vol. 91, no. 10, pp. 3527–3561, 1998. View at Google Scholar · View at Scopus
  9. C. M. Sena, A. M. Pereira, and R. Seiça, “Endothelial dysfunction—a major mediator of diabetic vascular disease,” Biochimica et Biophysica Acta: Molecular Basis of Disease, vol. 1832, no. 12, pp. 2216–2231, 2013. View at Publisher · View at Google Scholar · View at Scopus
  10. J. E. Deanfield, J. P. Halcox, and T. J. Rabelink, “Endothelial function and dysfunction: testing and clinical relevance,” Circulation, vol. 115, no. 10, pp. 1285–1295, 2007. View at Publisher · View at Google Scholar · View at Scopus
  11. W. Wang, M. Deng, X. Liu, W. Ai, Q. Tang, and J. Hu, “TLR4 activation induces nontolerant inflammatory response in endothelial cells,” Inflammation, vol. 34, no. 6, pp. 509–518, 2011. View at Publisher · View at Google Scholar · View at Scopus
  12. T. M. Carlos and J. M. Harlan, “Leukocyte-endothelial adhesion molecules,” Blood, vol. 84, no. 7, pp. 2068–2101, 1994. View at Google Scholar · View at Scopus
  13. Y. Zheng, S. E. Gardner, and M. C. H. Clarke, “Cell death, damage-associated molecular patterns, and sterile inflammation in cardiovascular disease,” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 31, no. 12, pp. 2781–2786, 2011. View at Publisher · View at Google Scholar
  14. A. Tedgui and Z. Mallat, “Cytokines in atherosclerosis: pathogenic and regulatory pathways,” Physiological Reviews, vol. 86, no. 2, pp. 515–581, 2006. View at Publisher · View at Google Scholar · View at Scopus
  15. A. Silveira, O. McLeod, R. J. Strawbridge et al., “Plasma IL-5 concentration and subclinical carotid atherosclerosis,” Atherosclerosis, vol. 239, no. 1, pp. 125–130, 2015. View at Publisher · View at Google Scholar · View at Scopus
  16. H. R. S. Girn, N. M. Orsi, and S. Homer-Vanniasinkam, “An overview of cytokine interactions in atherosclerosis and implications for peripheral arterial disease,” Vascular Medicine, vol. 12, no. 4, pp. 299–309, 2007. View at Publisher · View at Google Scholar · View at Scopus
  17. M. V. Autieri, “Pro- and anti-inflammatory cytokine networks in atherosclerosis,” ISRN Vascular Medicine, vol. 2012, Article ID 987629, 17 pages, 2012. View at Publisher · View at Google Scholar
  18. H. Ait-Oufella, S. Taleb, Z. Mallat, and A. Tedgui, “Recent advances on the role of cytokines in atherosclerosis,” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 31, no. 5, pp. 969–979, 2011. View at Publisher · View at Google Scholar · View at Scopus
  19. X. M. Feng, X. L. Chen, N. Liu et al., “Interleukin-27 upregulates major histocompatibility complex class II expression in primary human endothelial cells through induction of major histocompatibility complex class II transactivator,” Human Immunology, vol. 68, no. 12, pp. 965–972, 2007. View at Publisher · View at Google Scholar · View at Scopus
  20. D. A. A. Vignali and V. K. Kuchroo, “IL-12 family cytokines: immunological playmakers,” Nature Immunology, vol. 13, no. 8, pp. 722–728, 2012. View at Publisher · View at Google Scholar · View at Scopus
  21. T. Yoshimoto and T. Yoshimoto, Eds., Cytokine Frontiers, Springer Japan, Tokyo, Japan, 2014.
  22. A. V. Villarino, E. Huang, and C. A. Hunter, “Understanding the pro- and anti-inflammatory properties of IL-27,” The Journal of Immunology, vol. 173, no. 2, pp. 715–720, 2004. View at Publisher · View at Google Scholar · View at Scopus
  23. J. S. Stumhofer and C. A. Hunter, “Advances in understanding the anti-inflammatory properties of IL-27,” Immunology Letters, vol. 117, no. 2, pp. 123–130, 2008. View at Publisher · View at Google Scholar · View at Scopus
  24. W.-L. Phan, Y.-T. Huang, and M.-C. Ma, “Interleukin-27 protects cardiomyocyte-like H9c2 cells against metabolic syndrome: role of STAT3 signaling,” BioMed Research International, vol. 2015, Article ID 689614, 10 pages, 2015. View at Publisher · View at Google Scholar
  25. T. Hirase, H. Hara, Y. Miyazaki et al., “Interleukin 27 inhibits atherosclerosis via immunoregulation of macrophages in mice,” American Journal of Physiology—Heart and Circulatory Physiology, vol. 305, no. 3, pp. H420–H429, 2013. View at Publisher · View at Google Scholar · View at Scopus
  26. C. Guzzo, A. Ayer, S. Basta, B. W. Banfield, and K. Gee, “IL-27 enhances LPS-induced proinflammatory cytokine production via upregulation of TLR4 expression and signaling in human monocytes,” The Journal of Immunology, vol. 188, no. 2, pp. 864–873, 2012. View at Publisher · View at Google Scholar · View at Scopus
  27. H. Nam, B. S. Ferguson, J. M. Stephens, and R. F. Morrison, “Impact of obesity on IL-12 family gene expression in insulin responsive tissues,” Biochimica et Biophysica Acta, vol. 1832, no. 1, pp. 11–19, 2013. View at Publisher · View at Google Scholar · View at Scopus
  28. M. Shimizu, M. Shimamura, T. Owaki et al., “Antiangiogenic and antitumor activities of IL-27,” Journal of Immunology, vol. 176, no. 12, pp. 7317–7324, 2006. View at Publisher · View at Google Scholar · View at Scopus
  29. W. Jin, Y. Zhao, W. Yan et al., “Elevated circulating interleukin-27 in patients with coronary artery disease is associated with dendritic cells, oxidized low-density lipoprotein, and severity of coronary artery stenosis,” Mediators of Inflammation, vol. 2012, Article ID 506283, 10 pages, 2012. View at Publisher · View at Google Scholar · View at Scopus
  30. J. Y. King, R. Ferrara, R. Tabibiazar et al., “Pathway analysis of coronary atherosclerosis,” Physiological Genomics, vol. 23, no. 1, pp. 103–118, 2005. View at Publisher · View at Google Scholar · View at Scopus
  31. M. Frosch, A. Strey, T. Vogl et al., “Myeloid-related proteins 8 and 14 are specifically secreted during interaction of phagocytes and activated endothelium and are useful markers for monitoring disease activity in pauciarticular-onset juvenile rheumatoid arthritis,” Arthritis and Rheumatism, vol. 43, no. 3, pp. 628–637, 2000. View at Publisher · View at Google Scholar · View at Scopus
  32. S. Bréchard, S. Plançon, and E. J. Tschirhart, “New insights into the regulation of neutrophil NADPH oxidase activity in the phagosome: a focus on the role of lipid and Ca2+ signaling,” Antioxidants & Redox Signaling, vol. 18, no. 6, pp. 661–676, 2013. View at Publisher · View at Google Scholar · View at Scopus
  33. M. Frosch, M. Ahlmann, T. Vogl et al., “The myeloid-related proteins 8 and 14 complex, a novel ligand of toll-like receptor 4, and interleukin-1β form a positive feedback mechanism in systemic-onset juvenile idiopathic arthritis,” Arthritis and Rheumatism, vol. 60, no. 3, pp. 883–891, 2009. View at Publisher · View at Google Scholar · View at Scopus
  34. K. S. Michelsen, M. H. Wong, P. K. Shah et al., “Lack of toll-like receptor 4 or myeloid differentiation factor 88 reduces atherosclerosis and alters plaque phenotype in mice deficient in apolipoprotein E,” Proceedings of the National Academy of Sciences of the United States of America, vol. 101, no. 29, pp. 10679–10684, 2004. View at Publisher · View at Google Scholar · View at Scopus
  35. T. Vogl, N. Leukert, K. Barczyk, K. Strupat, and J. Roth, “Biophysical characterization of S100A8 and S100A9 in the absence and presence of bivalent cations,” Biochimica et Biophysica Acta, vol. 1763, no. 11, pp. 1298–1306, 2006. View at Publisher · View at Google Scholar · View at Scopus
  36. M. M. Averill, S. Barnhart, L. Becker et al., “S100A9 differentially modifies phenotypic states of neutrophils, macrophages, and dendritic cells: implications for atherosclerosis and adipose tissue inflammation,” Circulation, vol. 123, no. 11, pp. 1216–1226, 2011. View at Publisher · View at Google Scholar · View at Scopus
  37. M. Ikemoto, H. Murayama, H. Itoh, M. Totani, and M. Fujita, “Intrinsic function of S100A8/A9 complex as an anti-inflammatory protein in liver injury induced by lipopolysaccharide in rats,” Clinica Chimica Acta, vol. 376, no. 1-2, pp. 197–204, 2007. View at Publisher · View at Google Scholar · View at Scopus
  38. K. Otsuka, F. Terasaki, M. Ikemoto et al., “Suppression of inflammation in rat autoimmune myocarditis by S100A8/A9 through modulation of the proinflammatory cytokine network,” European Journal of Heart Failure, vol. 11, no. 3, pp. 229–237, 2009. View at Publisher · View at Google Scholar · View at Scopus
  39. E. A. Jaffe, R. L. Nachman, C. G. Becker, and C. R. Minick, “Culture of human endothelial cells derived from umbilical veins. Identification by morphologic and immunologic criteria,” The Journal of Clinical Investigation, vol. 52, no. 11, pp. 2745–2756, 1973. View at Publisher · View at Google Scholar · View at Scopus
  40. E. Willems, L. Leyns, and J. Vandesompele, “Standardization of real-time PCR gene expression data from independent biological replicates,” Analytical Biochemistry, vol. 379, no. 1, pp. 127–129, 2008. View at Publisher · View at Google Scholar · View at Scopus
  41. R Core Team, R: A Language and Environment for Statistical Computing, R Foundation for Statistical Computing, Vienna, Austria, 2014.
  42. W. Huber, A. von Heydebreck, H. Sültmann, A. Poustka, and M. Vingron, “Variance stabilization applied to microarray data calibration and to the quantification of differential expression,” Bioinformatics, vol. 18, supplement 1, pp. S96–S104, 2002. View at Publisher · View at Google Scholar · View at Scopus
  43. M. E. Ritchie, B. Phipson, D. Wu et al., “limma powers differential expression analyses for RNA-sequencing and microarray studies,” Nucleic Acids Research, vol. 43, no. 7, article e47, 2015. View at Publisher · View at Google Scholar
  44. G. K. Smyth, “Limma: linear models for microarray data,” in Bioinformatics and Computational Biology Solutions Using R and Bioconductor, R. Gentleman, V. J. Carey, W. Huber, R. A. Irizarry, and S. Dudoit, Eds., pp. 397–420, Springer, 2005. View at Publisher · View at Google Scholar
  45. L. Ting, M. J. Cowley, S. L. Hoon, M. Guilhaus, M. J. Raftery, and R. Cavicchioli, “Normalization and statistical analysis of quantitative proteomics data generated by metabolic labeling,” Molecular and Cellular Proteomics, vol. 8, no. 10, pp. 2227–2242, 2009. View at Publisher · View at Google Scholar · View at Scopus
  46. J. D. Storey and R. Tibshirani, “Statistical significance for genomewide studies,” Proceedings of the National Academy of Sciences of the United States of America, vol. 100, no. 16, pp. 9440–9445, 2003. View at Publisher · View at Google Scholar · View at MathSciNet · View at Scopus
  47. H. Wickham, ggplot2: Elegant Graphics for Data Analysis, Springer, New York, NY, USA, 2009.
  48. R. Pepper, The role of calprotectin (S100A8/A9) in the pathogenesis of glomerulonephritis and ANCA-associated vasculitis [Ph.D. thesis], University College London, London, UK, 2013.
  49. J. Diegelmann, T. Olszak, B. Göke, R. S. Blumberg, and S. Brand, “A novel role for interleukin-27 (IL-27) as mediator of intestinal epithelial barrier protection mediated via differential signal transducer and activator of transcription (STAT) protein signaling and induction of antibacterial and anti-inflammatory proteins,” Journal of Biological Chemistry, vol. 287, no. 1, pp. 286–298, 2012. View at Publisher · View at Google Scholar · View at Scopus
  50. Y. Iwasaki, K. Fujio, T. Okamura, and K. Yamamoto, “Interleukin-27 in T cell immunity,” International Journal of Molecular Sciences, vol. 16, no. 2, pp. 2851–2863, 2015. View at Publisher · View at Google Scholar · View at Scopus
  51. H. Ait-Oufella, S. Taleb, Z. Mallat, and A. Tedgui, “Cytokine network and T cell immunity in atherosclerosis,” Seminars in Immunopathology, vol. 31, no. 1, pp. 23–33, 2009. View at Publisher · View at Google Scholar · View at Scopus
  52. M. M. McCormick, F. Rahimi, Y. V. Bobryshev et al., “S100A8 and S100A9 in human arterial wall: implications for atherogenesis,” The Journal of Biological Chemistry, vol. 280, no. 50, pp. 41521–41529, 2005. View at Publisher · View at Google Scholar · View at Scopus
  53. L. Pedersen, M. Nybo, M. K. Poulsen, J. E. Henriksen, J. Dahl, and L. M. Rasmussen, “Plasma calprotectin and its association with cardiovascular disease manifestations, obesity and the metabolic syndrome in type 2 diabetes mellitus patients,” BMC Cardiovascular Disorders, vol. 14, no. 1, article 196, 2014. View at Publisher · View at Google Scholar
  54. D. Viemann, K. Barczyk, T. Vogl et al., “MRP8/MRP14 impairs endothelial integrity and induces a caspase-dependent and -independent cell death program,” Blood, vol. 109, no. 6, pp. 2453–2460, 2007. View at Publisher · View at Google Scholar · View at Scopus
  55. V. Gautier, E. Mouton-Barbosa, D. Bouyssiea et al., “Label-free quantification and shotgun analysis of complex proteomes by one-dimensional SDS-page/NanoLC-MS: evaluation for the large scale analysis of inflammatory human endothelial cells,” Molecular and Cellular Proteomics, vol. 11, no. 8, pp. 527–539, 2012. View at Publisher · View at Google Scholar · View at Scopus
  56. D. G. Tunica, X. Yin, A. Sidibe et al., “Proteomic analysis of the secretome of human umbilical vein endothelial cells using a combination of free-flow electrophoresis and nanoflow LC-MS/MS,” Proteomics, vol. 9, no. 21, pp. 4991–4996, 2009. View at Publisher · View at Google Scholar · View at Scopus
  57. J. D. Storey, “The positive false discovery rate: a Bayesian interpretation and the q-value,” The Annals of Statistics, vol. 31, no. 6, pp. 2013–2035, 2003. View at Publisher · View at Google Scholar · View at MathSciNet · View at Scopus
  58. F. Mach, A. Sauty, A. S. Iarossi et al., “Differential expression of three t lymphocyte-activating CXC chemokines by human atheroma-associated cells,” The Journal of Clinical Investigation, vol. 104, no. 8, pp. 1041–1050, 1999. View at Publisher · View at Google Scholar · View at Scopus
  59. S. Stemme, J. Holm, and G. K. Hansson, “T lymphocytes in human atherosclerotic plaques are memory cells expressing CD45RO and the integrin VLA-1,” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 12, no. 2, pp. 206–211, 1992. View at Publisher · View at Google Scholar · View at Scopus
  60. J.-C. Grivel, O. Ivanova, N. Pinegina et al., “Activation of T lymphocytes in atherosclerotic plaques,” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 31, no. 12, pp. 2929–2937, 2011. View at Publisher · View at Google Scholar · View at Scopus
  61. M. Müller, S. Carter, M. J. Hofer, and I. L. Campbell, “Review: the chemokine receptor CXCR3 and its ligands CXCL9, CXCL10 and CXCL11 in neuroimmunity—a tale of conflict and conundrum,” Neuropathology and Applied Neurobiology, vol. 36, no. 5, pp. 368–387, 2010. View at Publisher · View at Google Scholar · View at Scopus
  62. G. S. V. Campanella, R. A. Colvin, and A. D. Luster, “CXCL10 can inhibit endothelial cell proliferation independently of CXCR3,” PloS ONE, vol. 5, no. 9, Article ID e12700, 2010. View at Google Scholar · View at Scopus
  63. S. Sarrazin, W. C. Lamanna, and J. D. Esko, “Heparan sulfate proteoglycans,” Cold Spring Harbor Perspectives in Biology, vol. 3, no. 7, 2011. View at Google Scholar · View at Scopus
  64. S. Hodge, G. Hodge, R. Flower, and P. Han, “Surface and intracellular interleukin-2 receptor expression on various resting and activated populations involved in cell-mediated immunity in human peripheral blood,” Scandinavian Journal of Immunology, vol. 51, no. 1, pp. 67–72, 2000. View at Publisher · View at Google Scholar · View at Scopus
  65. N. Oppenheimer-Marks, R. I. Brezinschek, M. Mohamadzadeh, R. Vita, and P. E. Lipsky, “Interleukin 15 is produced by endothelial cells and increases the transendothelial migration of T cells in vitro and in the SCID mouse-human rheumatoid arthritis model in vivo,” Journal of Clinical Investigation, vol. 101, no. 6, pp. 1261–1272, 1998. View at Publisher · View at Google Scholar · View at Scopus
  66. R. Nischt, C. Schmidt, N. Mirancea et al., “Lack of nidogen-1 and -2 prevents basement membrane assembly in skin-organotypic coculture,” Journal of Investigative Dermatology, vol. 127, no. 3, pp. 545–554, 2007. View at Publisher · View at Google Scholar · View at Scopus
  67. B. Grimpe, J. C. Probst, and G. Hager, “Suppression of nidogen-1 translation by antisense targeting affects the adhesive properties of cultured astrocytes,” Glia, vol. 28, no. 2, pp. 138–149, 1999. View at Publisher · View at Google Scholar · View at Scopus
  68. K. Futyma, P. Miotła, K. Rózyńska et al., “Expression of genes encoding extracellular matrix proteins: a macroarray study,” Oncology Reports, vol. 32, no. 6, pp. 2349–2353, 2014. View at Publisher · View at Google Scholar · View at Scopus
  69. P. Gunning, G. O'Neill, and E. Hardeman, “Tropomyosin-based regulation of the actin cytoskeleton in time and space,” Physiological Reviews, vol. 88, no. 1, pp. 1–35, 2008. View at Publisher · View at Google Scholar · View at Scopus
  70. J. S. Y. Lee and A. I. Gotlieb, “Understanding the role of the cytoskeleton in the complex regulation of the endothelial repair,” Histology and Histopathology, vol. 18, no. 3, pp. 879–887, 2003. View at Google Scholar · View at Scopus
  71. S. Zhu, M.-L. Si, H. Wu, and Y.-Y. Mo, “MicroRNA-21 targets the tumor suppressor gene tropomyosin 1 (TPM1),” The Journal of Biological Chemistry, vol. 282, no. 19, pp. 14328–14336, 2007. View at Publisher · View at Google Scholar · View at Scopus
  72. E. Raitoharju, L.-P. Lyytikäinen, M. Levula et al., “miR-21, miR-210, miR-34a, and miR-146a/b are up-regulated in human atherosclerotic plaques in the Tampere Vascular Study,” Atherosclerosis, vol. 219, no. 1, pp. 211–217, 2011. View at Publisher · View at Google Scholar · View at Scopus
  73. C. Lubeseder-Martellato, E. Guenzi, A. Jörg et al., “Guanylate-binding protein-1 expression is selectively induced by inflammatory cytokines and is an activation marker of endothelial cells during inflammatory diseases,” The American Journal of Pathology, vol. 161, no. 5, pp. 1749–1759, 2002. View at Publisher · View at Google Scholar · View at Scopus
  74. J. Pammer, C. Reinisch, P. Birner, K. Pogoda, M. Sturzl, and E. Tschachler, “Interferon-α prevents apoptosis of endothelial cells after short-term exposure but induces replicative senescence after continuous stimulation,” Laboratory Investigation, vol. 86, no. 10, pp. 997–1007, 2006. View at Publisher · View at Google Scholar · View at Scopus
  75. L. Wang, E. W. Y. Chang, S. Wong, S.-M. Ong, D. Q. Y. Chong, and K. L. Ling, “Increased myeloid-derived suppressor cells in gastric cancer correlate with cancer stage and plasma S100A8/A9 proinflammatory proteins,” Journal of Immunology, vol. 190, no. 2, pp. 794–804, 2013. View at Publisher · View at Google Scholar · View at Scopus
  76. W. A. Muller, S. A. Weigl, X. Deng, and D. M. Phillips, “PECAM-1 is required for transendothelial migration of leukocytes,” Journal of Experimental Medicine, vol. 178, no. 2, pp. 449–460, 1993. View at Publisher · View at Google Scholar · View at Scopus
  77. W. Martinet, H. De Loof, and G. R. Y. De Meyer, “MTOR inhibition: a promising strategy for stabilization of atherosclerotic plaques,” Atherosclerosis, vol. 233, no. 2, pp. 601–607, 2014. View at Publisher · View at Google Scholar · View at Scopus
  78. M. A. Mueller, F. Beutner, D. Teupser, U. Ceglarek, and J. Thiery, “Prevention of atherosclerosis by the mTOR inhibitor everolimus in LDLR-/- mice despite severe hypercholesterolemia,” Atherosclerosis, vol. 198, no. 1, pp. 39–48, 2008. View at Publisher · View at Google Scholar · View at Scopus
  79. S. Fukumoto, M. Hiroi, P. Dirgahayu et al., “Suppression of IP-10/CXCL10 gene expression in LPS- and/or IFN-γ-stimulated macrophages by parasite-secreted products,” Cellular Immunology, vol. 276, no. 1-2, pp. 101–109, 2012. View at Publisher · View at Google Scholar · View at Scopus